When the Risk of Febrile Neutropenia Is 20%, Prophylactic Colony-Stimulating Factor Use Is Clinically Effective, but Is It Cost-Effective?
- 1 July 2006
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 24 (19) , 2975-2977
- https://doi.org/10.1200/jco.2006.05.6812
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- 2006 Update of Recommendations for the Use of White Blood Cell Growth Factors: An Evidence-Based Clinical Practice GuidelineJournal of Clinical Oncology, 2006
- Cost-Effectiveness of Adding Granulocyte Colony-Stimulating Factor to Primary Prophylaxis With Antibiotics in Small-Cell Lung CancerJournal of Clinical Oncology, 2006
- Insurance Status and the Use of Guideline Therapy in the Treatment of Selected CancersJournal of Clinical Oncology, 2005
- Using Practice Guidelines to Assess Cancer Care QualityJournal of Clinical Oncology, 2005
- Prevention of Chemotherapy-Induced Febrile Neutropenia by Prophylactic Antibiotics Plus or Minus Granulocyte Colony-Stimulating Factor in Small-Cell Lung Cancer: A Dutch Randomized Phase III StudyJournal of Clinical Oncology, 2005
- Guidelines of the National Comprehensive Cancer Network on the Use of Myeloid Growth Factors with Cancer Chemotherapy: A Review of the EvidenceJournal of the National Comprehensive Cancer Network, 2005
- First and Subsequent Cycle Use of Pegfilgrastim Prevents Febrile Neutropenia in Patients With Breast Cancer: A Multicenter, Double-Blind, Placebo-Controlled Phase III StudyJournal of Clinical Oncology, 2005
- G-CSF as prophylaxis of febrile neutropenia in SCLCExpert Opinion on Pharmacotherapy, 2002
- Growth Factor Usage Patterns and Outcomes in the Community Setting: Collection Through a Practice-Based Computerized Clinical Information SystemJournal of Clinical Oncology, 2000
- Use of Hematopoietic Colony-Stimulating Factors: Comparison of the 1994 and 1997 American Society of Clinical Oncology Surveys Regarding ASCO Clinical Practice GuidelinesJournal of Clinical Oncology, 1999